0 rating

Report from the American College 
of Rheumatology Annual Scientific Meeting 2010

Eric Ruderman, MD

The annual scientific meeting of the American College of Rheumatology (ACR) is always a source of new information on therapies for rheumatic diseases. This year’s meeting was notable not only for the information presented on new therapies, but also for the wealth of data presented on existing therapies and the best ways in which to use them. There were several well-attended didactic sessions addressing issues of therapy, including a state of the art lecture on the use of methotrexate and a debate on the use of biological therapy early in the course of rheumatoid arthritis (RA); however, a full review of these presentations is beyond the scope of this report. Instead, this review will highlight key abstracts presented at the meeting that dealt with the efficacy and safety of rheumatic disease therapies.

Return to top